BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31094929)

  • 1. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
    Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
    El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
    Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum.
    Urano M; Nakaguro M; Yamamoto Y; Hirai H; Tanigawa M; Saigusa N; Shimizu A; Tsukahara K; Tada Y; Sakurai K; Isomura M; Okumura Y; Yamaguchi H; Matsubayashi J; Nagao T
    Am J Surg Pathol; 2019 Jul; 43(7):984-994. PubMed ID: 30994537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.
    Geyer FC; Li A; Papanastasiou AD; Smith A; Selenica P; Burke KA; Edelweiss M; Wen HC; Piscuoglio S; Schultheis AM; Martelotto LG; Pareja F; Kumar R; Brandes A; Fan D; Basili T; Da Cruz Paula A; Lozada JR; Blecua P; Muenst S; Jungbluth AA; Foschini MP; Wen HY; Brogi E; Palazzo J; Rubin BP; Ng CKY; Norton L; Varga Z; Ellis IO; Rakha EA; Chandarlapaty S; Weigelt B; Reis-Filho JS
    Nat Commun; 2018 May; 9(1):1816. PubMed ID: 29739933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Tanigawa M; Hirai H; Yamamoto Y; Urano M; Takahashi RH; Sukeda A; Okumura Y; Honda S; Tasaki K; Shimizu A; Tsukahara K; Tada Y; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 Jul; 45(7):885-894. PubMed ID: 33481388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of
    Pareja F; Geyer FC; Brown DN; Sebastião APM; Gularte-Mérida R; Li A; Edelweiss M; Da Cruz Paula A; Selenica P; Wen HY; Jungbluth AA; Varga Z; Palazzo J; Rubin BP; Ellis IO; Brogi E; Rakha EA; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2019; 5():6. PubMed ID: 30675516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity.
    Ginter PS; McIntire PJ; Kurtis B; Mirabelli S; Motanagh S; Hoda S; Elemento O; Shin SJ; Mosquera JM
    Mod Pathol; 2020 Sep; 33(9):1764-1772. PubMed ID: 32355271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
    Pareja F; Toss MS; Geyer FC; da Silva EM; Vahdatinia M; Sebastiao APM; Selenica P; Szatrowski A; Edelweiss M; Wen HY; Mihai R; Varga Z; Foschini MP; Rubin BP; Ellis IO; Chandarlapaty S; Jungbluth AA; Brogi E; Weigelt B; Reis-Filho JS; Rakha EA
    Histopathology; 2020 May; 76(6):865-874. PubMed ID: 31887226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
    J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
    Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary epithelial-myoepithelial carcinoma without AKT1, HRAS or PIK3CA mutations: a case report.
    Yanagawa N; Sato A; Nishiya M; Suzuki M; Sugimoto R; Osakabe M; Uesugi N; Saito H; Sugai T
    Diagn Pathol; 2020 Aug; 15(1):105. PubMed ID: 32859224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary Epithelial-Myoepithelial Carcinoma: Report of a Case With HRAS and PIK3CA Mutations by Next-Generation Sequencing.
    Baum JE; Sung KJ; Tran H; Song W; Ginter PS
    Int J Surg Pathol; 2019 Jun; 27(4):441-445. PubMed ID: 30585117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
    Bièche I; Coussy F; El-Botty R; Vacher S; Château-Joubert S; Dahmani A; Montaudon E; Reyes C; Gentien D; Reyal F; Ricci F; Nicolas A; Marchio C; Vincent-Salomon A; Laé M; Marangoni E
    J Hematol Oncol; 2021 Sep; 14(1):143. PubMed ID: 34496925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations.
    Guillet C; Rechsteiner M; Bellini E; Choschzick M; Moskovszky L; Dedes K; Papassotiropoulos B; Varga Z
    Hum Pathol; 2020 Apr; 98():64-73. PubMed ID: 32088208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Nagao T
    Surg Pathol Clin; 2021 Mar; 14(1):97-109. PubMed ID: 33526226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
    Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
    Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA.
    Shalmon B; Drendel M; Wolf M; Hirshberg A; Cohen Y
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):721-5. PubMed ID: 26811072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.
    Antonescu CR; Zhang L; Shao SY; Mosquera JM; Weinreb I; Katabi N; Fletcher CD
    Genes Chromosomes Cancer; 2013 Jul; 52(7):675-82. PubMed ID: 23630011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.